Clinical Trial Update: A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 study of RC108-ADC in patients with advanced digestive system malignant tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• RC108-ADC

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Digestive Cancer | Phase 2 | Status: COMPLETED